Sources | Names Used |
---|---|
CTRPv2 | selumetinib:UNC0638 (4:1 mol/mol) |
PharmacoGx | selumetinib:UNC0638 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CRYL1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | RP4-635E18.9 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | DUSP6 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | AGPAT2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | CCNA2 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | FAM120C | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | SMAGP | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
mRNA | BARD1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | PLK3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |